NADPH Oxidase and Cardiac Failure

被引:66
作者
Kuroda, Junya [1 ]
Sadoshima, Junichi [1 ]
机构
[1] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA
关键词
NADPH Oxidase; Cardiac Failure; O-2(-); Reactive Oxygen Species; Apoptosis; Cardiac Myocytes; Hypertrophy; Mitochondrial Dysfunction; MITOCHONDRIAL OXIDATIVE STRESS; OXYGEN-FREE-RADICALS; HEART-FAILURE; ANGIOTENSIN-II; REACTIVE OXYGEN; FAILING MYOCARDIUM; PRESSURE-OVERLOAD; NAD(P)H OXIDASE; MUSCLE-CELLS; NOX FAMILY;
D O I
10.1007/s12265-010-9184-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increases in oxidative stress in the heart play an important role in mediating hypertrophy, apoptosis, fibrosis, mitochondrial dysfunction, and the consequent development of heart failure. Although it has been widely believed that electron leakage from the mitochondrial electron transport chain is the primary source of oxidative stress in the failing heart, increasing lines of evidence suggest that enzymes which produce reactive oxygen species may also contribute to it. NADPH oxidases are transmembrane enzymes dedicated to producing superoxide (O-2(-)) by transferring an electron from NAD(P)H to molecular oxygen. Nox4 is a major NADPH oxidase isoform expressed in the heart. Nox4 is localized primarily at mitochondria in cardiac myocytes, and upregulation of Nox4 hypertrophic stimuli enhances O-2(-) production, apoptosis, and mitochondrial dysfunction, thereby playing an important role in mediating cardiac dysfunction. Since Nox4 could be a key molecule mediating oxidative stress and pathological hypertrophy, it may serve as an important target of heart failure treatment. In this review, the importance of NADPH oxidases as sources of increased oxidative stress in the failing heart and the role of Nox4 in mediating growth and death of cardiac myocytes are discussed.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 58 条
  • [1] AGO T, 2010, CIRCULATION IN PRESS
  • [2] A redox-dependent pathway for regulating class IIHDACs and cardiac hypertrophy
    Ago, Tetsuro
    Liu, Tong
    Zhai, Peiyong
    Chen, Wei
    Li, Hong
    Molkentin, Jeffery D.
    Vatner, Stephen F.
    Sadoshima, Junichi
    [J]. CELL, 2008, 133 (06) : 978 - 993
  • [3] NADPH oxidase signaling and cardiac myocyte function
    Akki, Ashwin
    Zhang, Min
    Murdoch, Colin
    Brewer, Alison
    Shah, Ajay M.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 47 (01) : 15 - 22
  • [4] NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts
    An, Sheng Jun
    Boyd, Ryan
    Zhu, Min
    Chapman, Alexander
    Pimentel, David R.
    Wang, Hui Di
    [J]. CARDIOVASCULAR RESEARCH, 2007, 75 (04) : 702 - 709
  • [5] Clinical Impact of Left Ventricular Hypertrophy and Implications for Regression
    Artham, Surya M.
    Lavie, Carl J.
    Milani, Richard V.
    Patel, Dharmendrakumar A.
    Verma, Anil
    Ventura, Hector O.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2009, 52 (02) : 153 - 167
  • [6] Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy
    Bäumer, AT
    Flesch, M
    Wang, XK
    Shen, QC
    Feuerstein, GZ
    Böhm, M
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (01) : 121 - 130
  • [7] The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
    Bedard, Karen
    Krause, Karl-Heinz
    [J]. PHYSIOLOGICAL REVIEWS, 2007, 87 (01) : 245 - 313
  • [8] BELCH JJF, 1991, BRIT HEART J, V65, P245
  • [9] Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice
    Bendall, JK
    Cave, AC
    Heymes, C
    Gall, N
    Shah, AM
    [J]. CIRCULATION, 2002, 105 (03) : 293 - 296
  • [10] Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
    Bergamini, Corinna
    Cicoira, Mariantonietta
    Rossi, Andrea
    Vassanelli, Corrado
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (05) : 444 - 452